CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sichuan Biokin Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sichuan Biokin Pharmaceutical Co Ltd
Baili Road, Strait LiangAn Science Park
Phone: +86 2885321013p:+86 2885321013 CHENGDU, SIC  611130  China Ticker: 688506688506
Business Summary
Sichuan Biokin Pharmaceutical Co Ltd is a China-based company mainly engaged in drug research and development, production and marketing. The Company is mainly engaged in two business sectors: chemical preparations and Chinese patent medicine preparations, and innovative biological medicine business. The Company's main products include propofol emulsion injection, dexmedetomidine hydrochloride injection, medium/long chain fat emulsion injection, ribavirin granules and other chemical preparations, Chaihuang granules and other Chinese patent medicine preparations. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2021Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Scientific Officer, General Manager YiZhu 59
Chief Financial Officer, Executive Deputy General Manager, Secretary of the Board, Director SuyaZhang 67 5/1/2014 11/1/2011
Deputy General Manager, Director JianKang 54 11/1/2011 11/1/2011
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,074 (As of 12/31/2022)
Outstanding Shares: 401,000,000 (As of 1/8/2024)
Stock Exchange: SHA
Fax Number: +86 2885320270


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024